Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
PFE:NYQ since
Global Blood Therapeutics IncRumoured05 Aug 202205 Aug 2022Rumoured-1.18%--
Biohaven Pharmaceutical Holding Co LtdAnnounced10 May 202210 May 2022Announced1.30%12.60bn
ReViral LtdDeal completed07 Apr 202207 Apr 2022Deal completed-6.81%525.00m
Arena Pharmaceuticals IncDeal completed13 Dec 202113 Dec 2021Deal completed-6.65%6.68bn
Trillium Therapeutics IncDeal completed23 Aug 202123 Aug 2021Deal completed1.13%2.21bn
Data delayed at least 15 minutes, as of Aug 05 2022 21:10 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.